<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04970849</url>
  </required_header>
  <id_info>
    <org_study_id>I2020001357</org_study_id>
    <nct_id>NCT04970849</nct_id>
  </id_info>
  <brief_title>Survey Study About Endoscopy During COVID-19 Pandemic for IBD Doctors</brief_title>
  <official_title>Patterns of Endoscopy During COVID-19 Pandemic: a Global Survey of Interventional Inflammatory Bowel Disease Practice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Performance of diagnostic or therapeutic endoscopic procedures in inflammatory bowel disease&#xD;
      (IBD) patients can be challenging during a viral pandemic; the main concerns being the safety&#xD;
      and protection of patients and health care providers (HCP). The aim of this study is to&#xD;
      identify endoscopic practice patterns and outcomes of IBD and coronavirus disease 19&#xD;
      (COVID-19) with a worldwide survey of HCP.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The 20-item survey questionnaire was sent to physician members of the American Society for&#xD;
      Gastrointestinal Endoscopy Special Interest Group in Interventional IBD, Chinese IBD Society&#xD;
      Endoscopy Interest Group, and the China Crohn's and Colitis Foundation. The data of the&#xD;
      survey was collected and analyzed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 15, 2021</start_date>
  <completion_date type="Actual">July 15, 2021</completion_date>
  <primary_completion_date type="Actual">July 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The influence of covid-19 pandemic on endoscopic practice by IBD endoscopist</measure>
    <time_frame>1 week</time_frame>
    <description>The incidence of scheduled IBD endoscopies were postponed or cancelled due to the pandemic.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of COVID19 in IBD patients who underwent endoscopy</measure>
    <time_frame>1 week</time_frame>
    <description>The percentage of IBD patients who underwent endoscopy since the outbreak was tested positive for COVID 19</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">200</enrollment>
  <condition>Inflammatory Bowel Diseases</condition>
  <arm_group>
    <arm_group_label>one group that is IBD endoscopist who perform the endoscopy for IBD patients</arm_group_label>
    <description>Complete the questionnaire online</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>observation</intervention_name>
    <description>IBD doctors who perform the endoscopy perform the questionnaire</description>
    <arm_group_label>one group that is IBD endoscopist who perform the endoscopy for IBD patients</arm_group_label>
    <other_name>endoscopy with no drug</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The content of survey included: The number of procedures, the indication of endoscopy, the&#xD;
        number of patients with IBD diagnosed Covid-19, and the influence of the epidemic situation&#xD;
        on the diagnosis and treatment of IBD.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Doctors who are involved in the endoscopic treatment of IBD patients;&#xD;
&#xD;
          2. The endoscopist reads and signs an informed consent online. -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Doctors who are not involved in the endoscopic treatment of IBD patients&#xD;
&#xD;
          2. Doctors who need the help of an agent, a witness, or someone else who can not complete&#xD;
             the questionnaire independently.&#xD;
&#xD;
          3. Other conditions that the researchers considered unsuitable for inclusion or&#xD;
             influenced the participants'ability to complete the study.-&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yan Chen</last_name>
    <role>Principal Investigator</role>
    <affiliation>浙江大学医学院附属第二医院</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Second Affiliated Hospital Zhejiang University School of Medicine</name>
      <address>
        <city>Zhengzhou</city>
        <state>Hangzhou</state>
        <zip>310000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Mao R, Liang J, Shen J, Ghosh S, Zhu LR, Yang H, Wu KC, Chen MH; Chinese Society of IBD, Chinese Elite IBD Union; Chinese IBD Quality Care Evaluation Center Committee. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020 May;5(5):425-427. doi: 10.1016/S2468-1253(20)30076-5. Epub 2020 Mar 11. Erratum in: Lancet Gastroenterol Hepatol. 2020 Jul;5(7):e6.</citation>
    <PMID>32171057</PMID>
  </results_reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>July 15, 2021</study_first_submitted>
  <study_first_submitted_qc>July 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2021</study_first_posted>
  <last_update_submitted>July 19, 2021</last_update_submitted>
  <last_update_submitted_qc>July 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The result of questionnaire can be shared</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>now is available</ipd_time_frame>
    <ipd_access_criteria>All the doctors</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

